CALCRL and acute myeloid leukemia: Some studies suggested that median survival times were longer among patients expressing low levels of CALCRL, both in patients without t(8 ; 21) (Supplementary Figure S2) [19] and in AML-M2 patients (Supplementary Figures 3A).